Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
When Prime Day arrives, it isn’t just shoppers who notice. This guide explains how amazon's prime coming. here's move...
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
CME is moving to introduce Bitcoin volatility futures that track market expectations of price swings, separate from B...
The S&P 500 is up this year, but history offers guidance on what comes next. Learn the patterns, risks, and practical...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Inflation isn’t just a headline—it's a real market force that tests how consumers spend on discretionary goods. Explo...
Hims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
Micron stock just popped again as banks boosted targets and demand signals showed improvement. This guide breaks down...
Mid-June market data show the Russell 2000 leading the pack, up around 18% year-to-date as small caps take the spotli...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...